Current role
Biotechnology · Healthcare
Board Member
2023-06-21–present
Matthew L. Sherman, M.D.
Board Member
Palvella Therapeutics, Inc. (PVLA)Equibles does not estimate personal net worth.
About Matthew L. Sherman, M.D.
Matthew L. Sherman, M.D. is recorded as Board Member at Palvella Therapeutics, Inc. (PVLA) since June 21, 2023. Palvella Therapeutics, Inc. reported in an 8-K filed June 26, 2023 that Matthew L. Sherman, M.D. was appointed Class III director, effective June 21, 2023. Palvella Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Palvella Therapeutics, Inc. includes Wesley H. Kaupinen (CEO and Board Member), George M. Jenkins (Chairman and Board Member), James Geraghty (Chairman) and 7 others.
“elected each of Stephen S. Yoder, Michael Richman, and Matthew L. Sherman, M.D. to the Company's Board of Directors as Class III directors, each to serve for a three-year term expiring at the 2026 annual meeting of stockholders”
Affiliation history
-
Current
2023-06-21–present
Company network
Leadership on record at Palvella Therapeutics, Inc.
- Wesley H. Kaupinen CEO, Board Member
- George M. Jenkins Chairman, Board Member
- James Geraghty Chairman
- Matthew E. Korenberg CFO
- Matthew Korenberg CFO
- Kathleen Goin COO
- Jeffrey Martini CTO
- Jeffrey Martini, Ph.D. CTO
- Christopher Kiritsy Board Member
- Elaine J. Heron Board Member